Anastomotic Outcomes in Idiopathic Pulmonary Fibrosis Patients Receiving Anti-Fibrotic Therapy: Experience of the Australian Lung Transplant Collaborative

被引：0
|
作者：
Mackintosh, J. [1 ]
Munsif, M. [2 ]
Thomson, C. [3 ]
Musk, M. [4 ]
Snell, G. [2 ]
Glanville, A. [3 ]
Chambers, D. [1 ]
Hopkins, P. [1 ]
机构：
[1] Prince Charles Hosp, Lung Transplant Unit, Brisbane, Qld, Australia
[2] The Alfred, Lung Transplant Serv, Melbourne, Vic, Australia
[3] St Vincents Hosp, Lung Transplant Unit, Sydney, NSW, Australia
[4] Royal Perth Hosp, Lung Transplant Unit, Perth, WA, Australia
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
205
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [21] Impact of an interstitial lung diseases Nurse on the compliance to anti-fibrotic drugs in patients with Idiopathic Pulmonary Fibrosis.
    Mendoza, Onofre Moran
    Aldhaheri, Sharina
    Mccarthy, Lynda
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [22] A review of Idiopathic Pulmonary Fibrosis patients on anti-fibrotic treatment in the mid west area
    Ryan, N.
    Ryan, P.
    Gleeson, E.
    Cullinan, M.
    Mcinerney, C.
    Casserly, B.
    O'Brien, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S441 - S442
  • [23] Impact of Pre-Transplant Anti-Fibrotic Therapy for IPF Upon Lung Transplant Outcomes
    Astor, T. L.
    Goldberg, H. J.
    Snyder, L.
    Courtwright, A.
    Hachem, R.
    Pena, T.
    Zaffiri, L.
    Criner, G. J.
    Budev, M. M.
    Thaniyavarn, T.
    Lazarus, H. M.
    Bender, S.
    Barakat, A.
    Breeze, J.
    LaCamera, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] A Description Of Anti-Fibrotic Therapy Prescribing Preferences Amongst Pulmonary Practitioners For The Management Of Idiopathic Pulmonary Fibrosis
    Jablonski, R.
    Frogameni, A.
    Brown, K. K.
    Kamangar, N.
    Murgu, S.
    Raparia, K.
    Ryu, J.
    Raoof, S.
    Suh, R. D.
    Edell, E. S.
    Kamp, D. W.
    Raj, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [25] The efficacy of anti-fibrotic agents for acute exacerbation of idiopathic pulmonary fibrosis
    Matsumoto, Yoko
    Furukawa, Ryutaro
    Ohara, Sayaka
    Usui, Kazuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [26] DISEASE PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS UNDER ANTI-FIBROTIC TREATMENT
    Cilli, Aykut
    Uzer, Fatih
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2023, 40 (03)
  • [27] Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis
    Hasaneen, Nadia
    Tuong Vu
    Fusiak, Timothy
    Foda, Hussein
    Condos, Rany
    Smaldone, Gerald
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [28] Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications
    Nair, Girish B.
    Matela, Ajsza
    Kurbanov, Daniel
    Raghu, Ganesh
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 699 - 711
  • [29] Real-world study evaluating anti-fibrotic therapy on survival in idiopathic pulmonary fibrosis
    Robertson, Lucy
    Barnes, Joshua
    Rogers, Kirstie
    Thillai, Muhunthan
    Parfrey, Helen
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [30] Anti-Fibrotic Therapy Modulates Mortality Risk Associated with Circulating Plasma Biomarkers in Patients with Idiopathic Pulmonary Fibrosis
    Sarma, N.
    Adegunsoye, A. O.
    Alqalyoobi, S.
    Bowman, W. S.
    Lee, C.
    Pugashetti, J. V.
    Linderholm, A.
    Ma, S.
    Haczku, A.
    Strek, M. E.
    Noth, I.
    Oldham, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345